UNSPSC 51283003: Clindamycin hydrochloride

This classification denotes a lincosamide antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T20OQ1YN1W. European Medicines Agency schedules Clindamycin hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01342MIG. Clindamycin hydrochloride generally arises in the molecular formula C18H33CLN2O5S.CLH. The term 'clindamycin hydrochloride' is a U.S. Pharmacopeial Convention designation.

UNSPSC 51283003 Clindamycin hydrochloride, a Commodity code, represents pharmaceutical inventory that state and local governments procure through both direct purchase and piggyback cooperative contracts. The actual purchasing activity under this code centers on antibiotic and pharmaceutical products supplied to health departments, county health systems, and emergency response programs. State and local bodies use cooperative purchasing vehicles—notably the MMCAP Infuse consortium—to aggregate demand and secure volume pricing on essential pharmaceutical inventory, reducing per-unit costs and streamlining procurement across multiple jurisdictions. Issuing bodies include state health departments and county governments with public health or emergency services missions.

Recent opportunities show Illinois Department of Public Health awarding a $2,999,999.11 piggyback pharmaceutical warehouse contract through MMCAP Infuse to Chartwell Rx LLC (Bid 26-482DPH-PREPD-B-53392, awarded August 28, 2026) for Doxycycline Hyclate and Ciprofloxacin Hydrochloride under an Invitation for Bid process with a 12-month initial term and two renewal options. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 (response due July 26, 2023) seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually via quarterly deliveries to the Seminole County Community Health Building. Recent activity concentrates in Florida and Illinois, though the cooperative purchasing model suggests broader geographic reach through MMCAP and similar consortia. Vendors pursuing this code should position capabilities around pharmaceutical logistics, contract compliance with E-Verify and drug-free workplace certification, and ability to meet quarterly or regular delivery schedules to fixed health department or county locations.